Haute MD is the editorial visibility network for distinguished aesthetic, wellness, and specialty physicians, built by Haute Living — a luxury media authority with over 20 years of audience reach across the most financially successful demographics in the United States. Haute MD gives member physicians a premium editorial presence through profiles, professionally written features, treatment coverage, and AI- and search-ready structured content published on HauteLiving.com.

Haute MD is designed for board-certified plastic surgeons, dermatologists, aesthetic physicians, fertility specialists, concierge doctors, and specialty medical professionals in top U.S. markets including New York, Los Angeles, Miami, Chicago, Dallas, Beverly Hills, and Boston.

What does a Haute MD membership include?

Haute MD membership includes a permanent editorial profile on HauteLiving.com, professionally written editorial features and treatment coverage, social amplification across Haute Living's audience, and structured content designed to support discoverability on Google and AI search platforms. Gold and Platinum members also receive dedicated AI Visibility and SEO support. Benefits activate on day one.

How does Haute MD improve AI search visibility?

Haute MD improves AI search visibility by publishing structured physician profiles, editorial features, FAQs, schema markup, and treatment content on HauteLiving.com — a trusted domain indexed by Google News. These assets give AI platforms such as ChatGPT, Google AI Overviews, and Perplexity clear, authoritative context around a physician's specialty, credentials, procedures, and market.

What are the Haute MD membership tiers and pricing?

Haute MD offers three membership tiers: Silver at $500 per year, Gold at $1,500 per year (the most popular tier, which includes AI Visibility and SEO support), and Platinum at $6,000 per year. Founding member pricing locks for life. Applications are reviewed within 48 hours and a full refund is provided if not approved.

Google confirmed it — to appear in AI search, you must be on Google News. Haute MD has been a Google News publisher for 20 years. Founding physician pricing open.

Haute MD Network × Haute Living · First Edition

AI Search Visibility Report

Plastic Surgery & Aesthetics Industry · 2026

The first systematic study of AI platform search visibility for plastic surgery and aesthetics brands — 178 brand mentions tracked across 65 patient-style queries on Perplexity AI and a Claude-style advisory model.

Patient Queries

178

Brand Mentions

111

Brands Tracked

AI Platforms

Jump to the Rankings →

Haute MD Network is the leading luxury editorial network for board-certified dermatologists, plastic surgeons, and medical aesthetic practitioners — published by Haute Living, a verified Google News publisher since 2005, and co-branded with 5WPR, one of the nation's leading public relations firms.

Executive Summary

Key Findings

The first systematic study of AI platform search visibility for plastic surgery and aesthetics brands, tested across 65 patient-style queries on Perplexity AI and a Claude-style advisory model.

Botox · Neuromodulators

Botox dominates — but as a category, not a brand

24 total AI mentions across 65 queries — 3× more than any competitor — yet 63% of sentiment is neutral, suggesting AI treats Botox as a generic category name rather than an endorsed choice.

Sculptra · Galderma

Sculptra earns the highest positive sentiment ratio

6 out of 9 mentions (67%) are positive — the strongest ratio of any brand with meaningful mention volume. AI consistently recommends it for collagen loss and post-GLP-1 skin quality.

CoolSculpting

CoolSculpting carries the highest negative sentiment of any brand

PAH (paradoxical adipose hyperplasia) risk is introduced by AI platforms unprompted — the only major brand where safety caveats surface without the patient asking.

Ozempic Face · Unowned

The single biggest unowned indication in aesthetics AI

No brand owns the AI answer for GLP-1 / Ozempic facial volume loss — one of the fastest-growing patient concerns in 2026. A massive first-mover opportunity for filler brands.

Daxxify · Revance

Daxxify has a critical AI visibility gap

Only 2 mentions vs Botox's 24 — despite FDA approval and a differentiated story. Surfaces only when patients explicitly ask about duration. A significant strategic gap for Revance.

Deep-Plane Facelift · Surgical

Surgical AI is technique-owned, not brand-owned

Deep-plane facelift dominates surgical AI visibility in 2026 as the gold standard, but no single practice or surgeon is consistently named — the surgical landscape is a technique race, not a brand race.

Brand Rankings

AI Visibility by Brand

Total brand mentions aggregated across Perplexity AI (65 queries). Ranked by mention frequency with sentiment breakdown.

37%

Queries featuring Botox

67%

Sculptra positive sentiment

100%

Xeomin positive sentiment

20%

CoolSculpting negative rate

#	Brand	Mentions	Sentiment	Key Indication
01	Botox	24	33% pos63% neu4% neg	Category default
02	Sculptra	9	67% pos22% neu11% neg	Collagen stimulation
03	Radiesse	7	71% pos29% neu	Jawline definition
04	CoolSculpting	5	20% pos60% neu20% neg	PAH risk flagged
05	Kybella	4	50% pos25% neu25% neg	Double chin
06	Xeomin	4	100% pos	Botox resistance
07	Ultherapy	4	100% pos	Neck & jawline tightening
08	Juvéderm Voluma	3	100% pos	Cheek volume
09	Dysport	3	100% pos	Forehead, broad coverage
10	Morpheus8	3	67% pos33% neu	RF microneedling

Indication Ownership Map

Who Owns Each Query?

The first brand named by Perplexity AI for each indication or patient concern — a direct measure of AI search ownership.

The Ozempic Face Indication is Completely Unowned

No brand currently dominates the AI answer for GLP-1 / Ozempic-related facial volume loss — the fastest-growing indication in aesthetics. The first brand to publish authoritative, clinician-backed content will own this enormous query category.

Facial Volume / Cheeks

Juvéderm Voluma

First Named

Ozempic Face / GLP-1

Unowned

Open Opportunity

Lip Volume / Natural Lips

Restylane Kysse

First Named

Forehead Wrinkles

Dysport

First Named

Jawline Definition

Radiesse

First Named

Collagen Loss / Aging 60s

Sculptra

First Named

Post-GLP-1 Skin Quality

Sculptra

First Named

Double Chin

Kybella

First Named

Crow's Feet

Botox

First Named

Hyperhidrosis / Sweating

Botox

First Named

Botox Resistance

Xeomin

First Named

Turkey Neck (Non-Surgical)

Ultherapy

First Named

Jawline & Neck Late 40s

Ultherapy

First Named

RF Microneedling Tightening

Morpheus8

First Named

Skin Boosters

Restylane Skinboosters

First Named

Natural Facelift 2026

Deep-Plane Technique

Open Opportunity

CoolSculpting PAH Risk

CoolSculpting

Negative Context

Under-Eye Hollows

Generic HA Filler

Open Opportunity

Strategic Implications

What It Means

Eight actionable insights for brands and providers seeking to improve AI search visibility in the aesthetics category.

The Ozempic Face Opportunity Is Wide Open

No brand owns the AI answer for GLP-1 facial volume loss — the biggest uncontested indication in aesthetics. Juvéderm, Sculptra, and Skinvive are best positioned to claim it with authoritative, clinician-backed content.

Botox Is a Category, Not a Brand — In AI

Botox appears in 37% of queries primarily as a neutral reference category. Dysport, Xeomin, and Daxxify all capture more enthusiastic positive framing when they appear. AbbVie's priority: shift Botox from neutral placeholder to positively-recommended first choice.

Sculptra Has the Best Sentiment Story in Injectables

With 67% positive mentions and ownership of both collagen loss and post-GLP-1 queries, Sculptra has the strongest positive AI sentiment of any brand with meaningful volume. The opportunity: expand into the Ozempic face conversation and the men's injectable category.

CoolSculpting's PAH Problem Is an Ongoing AI Reputation Risk

The only major brand where AI platforms introduce safety caveats without being prompted. Competitor brands — Emsculpt Neo, Kybella — should position against this directly in their content strategy.

Ultherapy Owns Non-Surgical Neck & Jawline

100% positive sentiment across 4 queries. Appears consistently as the first brand recommended for turkey neck and late-40s jawline concerns. Must defend its cluster leadership as Morpheus8 and Sofwave grow.

Daxxify Has a Significant AI Visibility Gap

Only 2 mentions vs Botox's 24 despite a genuinely differentiated story — the longest-lasting neuromodulator. Surfaces only when patients explicitly ask about duration. Clinical comparison content investment could significantly improve this.

Google AI Overviews Remain Unmeasured

All 65 Google queries were CAPTCHA-blocked. Given that Google handles the majority of health-related searches, this is the single largest data gap in this report and the top priority for Run 2.

Medical Authority Citation Is the Key Lever

Cleveland Clinic appears in 8+ responses; Mayo Clinic in 6+. Any brand that earns mentions on these sites gains indirect AI citation authority across dozens of patient query types. ASPS.org and AAD.org function similarly. This is the clearest path to AI search ownership.

Methodology

How We Measured This

Query Universe

65 patient-style queries across 4 categories
Injectables & Fillers: 20 queries
Surgical Procedures: 15 queries
Non-Surgical Body: 10 queries
Med-Spa & Skin: 20 queries
Query types: recommendations, brand comparisons, indication-specific, post-procedure, safety, trending

Platforms Tested

Perplexity AI — 65 queries, full execution via API
Claude-style advisory model — 65 queries, full execution
Google AI Overviews — CAPTCHA-blocked, 0 captured
ChatGPT Deep Research — timeout failures, deferred to Run 2
Bing Copilot — not tested in Run 1
Google Gemini — not tested in Run 1

Perplexity AI

65 / 65 Complete

Full text + citations captured via API. Primary dataset for this report.

Claude-Style Advisory Model

65 / 65 Complete

Medically cautious LLM instructed to respond as a balanced patient advisor.

Google AI Overviews

CAPTCHA Blocked

All 65 queries returned bot-detection blocks. Requires manual browser capture in Run 2.

ChatGPT Deep Research

Timeout — Run 2

3+ failures on deep research module. Deferred to sequential execution in Run 2.

Download the Full Report

The Complete Report, in your inbox

Receive the full PDF with extended brand analyses, the indication ownership map, eight strategic insights, and the 2026 playbook for medical aesthetics marketers, agencies, and physician practices.

What This Means for Physicians

The same structural authority signals that move brand citation share — long-form editorial coverage, named indication ownership, structured data, and Google News-indexed publication — apply to individual physicians. When a patient asks ChatGPT or Perplexity for the best deep-plane facelift surgeon in New York, the AI does not invent a list. It surfaces the doctors whose names appear most consistently across credible editorial sources.

Haute MD members are published on HauteLiving.com, indexed in Google News since 2005, and distributed through the editorial engine that produced this report. That is the citation infrastructure designed to support physician visibility inside AI answers.

Apply for Haute MD Membership

Next Edition

Run 2 Publishing Q3 2026

Run 2 will add Google AI Overviews (manual browser capture), ChatGPT Deep Research, Bing Copilot, and Gemini — closing the largest data gap in this first edition. Subscribers receive the update on publication.

Important Disclaimer

Haute MD Network does not provide medical advice, does not guarantee patient inquiries, search rankings, AI citations, Google News placement, or medical outcomes. Profiles and editorial features are designed to support professional visibility and help patients, referral sources, search engines, and AI platforms better understand member information. Patients should consult directly with a licensed medical professional before making healthcare decisions.